Xcancer

Omaha, Nebraska 68130

4 studies enrolling now · 10 studies all time

What they study most

B7H3, Biochemical Recurrence of Malignant Neoplasm of Prostate, Castration Resistant Metastatic Prostate Cancer, Castration-Resistant Prostate Cancer (CRPC), Cervical Cancer, Clear Cell Renal Cell Carcinoma, Colorectal Cancer, Cryotherapy, Endometrial Cancer, Esophageal Squamous Cell Carcinoma (ESCC), Head &Amp; Neck Squamous Cell Carcinoma (HNSCC), Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Studies at this site

• A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer — Recruiting now
• Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer — Recruiting now
• 64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE) — Recruiting now
• 177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors — Recruiting now
• 89Zr-DFO-girentuximab Expanded Access Program (EAP) — NO_LONGER_AVAILABLE
• 64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate Cancer — Running, not enrolling
• FPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) — Running, not enrolling
• Study of Alpha Radioligand Therapy AB001 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) — Running, not enrolling
• Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer — Completed
• Piflufolastat F 18 PET/CT in Patients With Suspected, or at High Risk for Metastatic ccRCC — Withdrawn before enrolling